0.3496
Adial Pharmaceuticals Inc stock is traded at $0.3496, with a volume of 403.12K.
It is down -1.99% in the last 24 hours and down -1.10% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$0.3567
Open:
$0.35
24h Volume:
403.12K
Relative Volume:
0.56
Market Cap:
$7.63M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.0605
EPS:
-5.78
Net Cash Flow:
$-7.34M
1W Performance:
-3.59%
1M Performance:
-1.10%
6M Performance:
-49.33%
1Y Performance:
-65.04%
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ADIL
Adial Pharmaceuticals Inc
|
0.3496 | 7.79M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spendingIPO Watch & Accurate Entry and Exit Point Alerts - newser.com
Has Adial Pharmaceuticals Inc. formed a bullish divergenceTrade Analysis Report & Low Drawdown Investment Strategies - newser.com
Real time social sentiment graph for Adial Pharmaceuticals Inc.Trade Volume Summary & Verified Chart Pattern Trade Signals - newser.com
Forecasting Adial Pharmaceuticals Inc. price range with options dataEarnings Recap Report & AI Driven Stock Reports - newser.com
Will Adial Pharmaceuticals Inc. stock continue upward momentumJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025Quarterly Investment Review & Reliable Volume Spike Alerts - newser.com
What high frequency data says about Adial Pharmaceuticals Inc.Gold Moves & Growth Focused Stock Pick Reports - newser.com
Heatmap analysis for Adial Pharmaceuticals Inc. and competitorsQuarterly Portfolio Report & Smart Investment Allocation Insights - newser.com
How hedge fund analytics apply to Adial Pharmaceuticals Inc. stockQuarterly Profit Summary & Safe Capital Growth Stock Tips - newser.com
Why analysts upgrade Adial Pharmaceuticals Inc. stockQuarterly Profit Report & Real-Time Buy Signal Notifications - newser.com
Is this a good reentry point in Adial Pharmaceuticals Inc.Weekly Investment Report & Real-Time Volume Analysis - newser.com
Can Adial Pharmaceuticals Inc. stock withstand economic slowdownWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com
Detecting price anomalies in Adial Pharmaceuticals Inc. with AIWeekly Market Outlook & Weekly Chart Analysis and Trade Guides - newser.com
Full technical analysis of Adial Pharmaceuticals Inc. stockRisk Management & Weekly Top Performers Watchlists - newser.com
Adial Pharmaceuticals Inc Stock Analysis and ForecastAnalyst Downgrades & Small Budget Capital Gains - earlytimes.in
How Adial Pharmaceuticals Inc. stock responds to policy changesJuly 2025 Fed Impact & Verified Chart Pattern Signals - fcp.pa.gov.br
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):